Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples